Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. 1998

Y Taoufik, and J Gasnault, and A Karaterki, and M Pierre Ferey, and E Marchadier, and C Goujard, and A Lannuzel, and J F Delfraissy, and E Dussaix
Department of Microbiology, Paul Brousse Hosptial, Cedex, France. yassine.taoufik@pbr.ap-hop-paris.fr

JC virus (JCV) load was determined by using quantitative polymerase chain reaction in cerebrospinal fluid (CSF) of 12 patients with AIDS-associated progressive multifocal leukoencephalopathy (PML) and compared with clinical outcome. JCV loads varied widely (3-7 log10 JCV equivalents/mL of CSF) and were apparently not related to absolute CD4 cell counts or CSF and plasma human immunodeficiency virus type 1 loads. A significant correlation was observed between JCV load and survival time (Spearman's rank correlation, -0.83; P<. 01). Moreover, CSF JCV load decreased and then became undetectable in 1 PML patient receiving cidofovir treatment, and this was associated with clinical improvement. These results show that CSF JCV load may be useful as a prognostic parameter and in monitoring the effectiveness of anti-JCV therapies in PML patients.

UI MeSH Term Description Entries
D007577 JC Virus A species of POLYOMAVIRUS, originally isolated from the brain of a patient with progressive multifocal leukoencephalopathy. The patient's initials J.C. gave the virus its name. Infection is not accompanied by any apparent illness but serious demyelinating disease can appear later, probably following reactivation of latent virus. Human Polyomavirus JC,JC polyomavirus,Polyomavirus, JC,John Cunningham Virus,Polyomavirus hominis 2,Polyomavirus JC, Human,Virus, John Cunningham
D008297 Male Males
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003596 Cytosine A pyrimidine base that is a fundamental unit of nucleic acids.
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077404 Cidofovir An acyclic nucleoside phosphonate that acts as a competitive inhibitor of viral DNA polymerases. It is used in the treatment of RETINITIS caused by CYTOMEGALOVIRUS INFECTIONS and may also be useful for treating HERPESVIRUS INFECTIONS. 1-((3-Hydroxy-2-phosphonylmethoxy)propyl)cytosine,1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine,Cidofovir Anhydrous,Cidofovir Sodium,Cidofovir, (+-)-isomer,Cidofovir, (R)-isomer,Cidofovir, Sodium Salt,GS 504,GS-504,HPMPC,Vistide,GS504

Related Publications

Y Taoufik, and J Gasnault, and A Karaterki, and M Pierre Ferey, and E Marchadier, and C Goujard, and A Lannuzel, and J F Delfraissy, and E Dussaix
February 1995, Journal of clinical microbiology,
Y Taoufik, and J Gasnault, and A Karaterki, and M Pierre Ferey, and E Marchadier, and C Goujard, and A Lannuzel, and J F Delfraissy, and E Dussaix
March 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Y Taoufik, and J Gasnault, and A Karaterki, and M Pierre Ferey, and E Marchadier, and C Goujard, and A Lannuzel, and J F Delfraissy, and E Dussaix
March 1995, Annals of neurology,
Y Taoufik, and J Gasnault, and A Karaterki, and M Pierre Ferey, and E Marchadier, and C Goujard, and A Lannuzel, and J F Delfraissy, and E Dussaix
April 1993, Journal of medical virology,
Y Taoufik, and J Gasnault, and A Karaterki, and M Pierre Ferey, and E Marchadier, and C Goujard, and A Lannuzel, and J F Delfraissy, and E Dussaix
January 1999, Neurology,
Y Taoufik, and J Gasnault, and A Karaterki, and M Pierre Ferey, and E Marchadier, and C Goujard, and A Lannuzel, and J F Delfraissy, and E Dussaix
January 1998, Archives of virology,
Y Taoufik, and J Gasnault, and A Karaterki, and M Pierre Ferey, and E Marchadier, and C Goujard, and A Lannuzel, and J F Delfraissy, and E Dussaix
December 1991, Neurology,
Y Taoufik, and J Gasnault, and A Karaterki, and M Pierre Ferey, and E Marchadier, and C Goujard, and A Lannuzel, and J F Delfraissy, and E Dussaix
June 2004, Arquivos de neuro-psiquiatria,
Y Taoufik, and J Gasnault, and A Karaterki, and M Pierre Ferey, and E Marchadier, and C Goujard, and A Lannuzel, and J F Delfraissy, and E Dussaix
December 2014, Annals of neurology,
Y Taoufik, and J Gasnault, and A Karaterki, and M Pierre Ferey, and E Marchadier, and C Goujard, and A Lannuzel, and J F Delfraissy, and E Dussaix
January 1994, AIDS (London, England),
Copied contents to your clipboard!